Neoadjuvant radiotherapy
Neoadjuvant radiotherapy is a radiation therapy with 20 clinical trials. Currently 8 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
9
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
8
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Three Fraction Radiation to Induce Immuno-Oncologic Response
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
Clinical Trials (20)
Three Fraction Radiation to Induce Immuno-Oncologic Response
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer
Neoadjuvant Radiotherapy for High-risk UTUC
Breast Reconstruction and Neoadjuvant Radiotherapy
Neoadjuvant Radiotherapy for Breast Cancer
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
Neoadjuvant Radiation in Locally Advanced Breast Cancer
Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test.
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer
Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers
MMP-7 Modulation by Short and Long Term Radiotherapy in Rectal Cancer Patients
All 20 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 20